Radioiodine Therapy- I-131 is a proven and effective method of completely removing the residual thyroid tissue or cancer once the thyroid has already been taken out.

Radioactive iodine (I-131), which is part of the thyroid cells, is used to treat the disorder. The released beta rays of iodine kill prominent thyroid cells in a dose such as 200 mci, reducing the possibility of cancer recurrence and dissipation. It is also referred to as radioiodine ablation.  

How I-131 Radioiodine Therapy Works?

The thyroid usually absorbs iodine to produce hormones that regulate metabolism. Almost complete excision of the thyroid can leave small pieces in the body or metastasize to other locations.  

At the time radioactive iodine (I-131) is administered:  

• The rest of the thyroid cells absorb the iodine.  
• These cells are killed by the beta rays.  
• This prevents recurrence of cancer and also enables the disease to be kept under control.  

Indications for I-131 Radioiodine Therapy – 200 mCi

This treatment is mainly prescribed when the patient experiences:  

• Removal of residual thyroid cells (post-surgical).  
• Papillary or follicular thyroid cancer treatment.  
• Treating thyroid cancer, which has spread to the lung, bones, or lymph nodes.  
• Lowering of the high levels of thyroglobulin after treatment.  
• Exterminating small cancer cells invisible through scans.  
• High-risk patients may be those whose tumor is aggressive or that the tumor has a tendency to recur.  

Preparation Before I-131 Therapy

TO generate the optimal therapy, the levels of TSH should be high to allow the remaining thyroid cells to absorb more iodine.  

Methods to Elevate TSH Levels

1. Thyroid Hormone Withdrawal Method

• Stop Thyronorm and/or other medications 3 to 6 weeks before treatment.  
• This leads to low thyroid (hypothyroidism, which increases TSH). 

Possible symptoms:

• Feeling tired.  
• Being cold easily.  
• Stomach slow movement.  
• Changing moods.  
• Gaining weight.  

This is an inexpensive and universal procedure, particularly in the absence of Thyrogen. 

2. Recombinant TSH (Thyrogen®) Injections

• Dose 2 is to be given into the muscle 24 hours apart.  
• Administer the iodine after the second dosage of 24 hours.  
• The thyroid hormone can be continued to be taken by patients.  

Advantages:  

• No hypothyroid symptoms.  
• Makes patients feel better. 

Note: This method costs more.  

Procedure for I-131 Radioiodine Therapy – 200 mCi

Pre-Therapy Evaluation

• The low-iodine diet should be consumed for 1 to 2 weeks.  
• Are blood tests on thyroglobulin and kidney functioning.  
• Carry out pregnancy tests on women who might conceive.

Hospital Admission

• The average length of stay is 1 to 3 days.  
• A special room where the radiation is kept is used by the patients.

Radioiodine Administration

• Use it orally as a pill or as a liquid.  
• Take with water under the observation of a doctor.

Post-Administration Care

• Stay isolated for 1 to 3 days.  
• Consume adequate water so that we can eliminate the radioactivity.  
• Wash your hands and obey toilet etiquette.  
• Check cash before discharge.  

Post-Therapy Recommendations

• Isolate, at least during a few days, the person, more so children, and expectant mothers.  
• Take thyroid medicine as ordered.  
• Eat a low‑iodine diet if told.  
• Phil must not get pregnant for a year.  

Follow-Up Includes:

• Test thyroglobulin in the blood.  
• Do a neck ultrasound.  
• Get a whole‑body scan with I‑131.

Benefits of I-131 Radioiodine Therapy

• It causes the death of only the thyroid tissue.  
• It assists patients in living a longer life.  
• It reduces the risk of recurrence of cancer.  
• The treatment is a mouthpiece, no operation.  
• Hospital stay is short.  
• It can be done again if needed. 

Possible Side Effects

I-131 therapy is generally safe, but some patients may experience:

• The slightest neck tenderness or swelling.  
• Dry mouth or taste changes.  
• Feeling ill or intestine-ache.  
• Glands in the mouth are swelling.  
• Throat pain.  
• Temporary period changes.  

Rare risks:

• Failure to have babies following numerous high doses.  
• Secondary malignancies (very rare)

Conclusion

Radioiodine Therapy at I-131 200mci is a very good modality of treating differentiated thyroid cancer, which has been surgically treated. It builds the natural capacity of the thyroid to absorb iodine to provide concentrated radiation, which kills residual cells and minute disease.  

This treatment, either by cessation of thyroid hormone or administration of TSH shots, prevents recurrence of cancer and enhances the long-term outcomes.  

The proper preparation, checkups, and follow-ups make it safe, dependable, and tested.  

Individuals who underwent a thyroidectomy or obtained a differentiated thyroid cancer should discuss this treatment with a nuclear medicine physician to determine whether this solution suits them.